YTM-15445-25275
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 363 / AL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
- 2020-12-30
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Sneezing — Feeling: FairFree text: Nasal stuffiness; sneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Fair · Fatigue or tirednessFree text: Mild Sore throat, congested noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-01-03
- 2021-01-04
- 2021-01-05
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-17
- 2021-03-04
- 2021-07-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Nasal stuffiness; sneezing
Systemic reaction (other): Mild Sore throat, congested nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release